Jillian Paull is a Senior Computational Biologist at Pfizer, where she develops computational methods and workflows to support nucleic acid products and medicines.
Prior to Pfizer, Jillian held a postdoctoral research position at the Broad Institute, where she helped develop a viral metagenomic pipeline to allow for real-time detection of diverse pathogens. During her PhD in systems biology at Harvard University, she sequenced clinical and wastewater SARS-CoV-2 samples and analyzed viral spread during outbreaks.
Jillian has also spent time living abroad, and considers herself to be a failed polyglot. She previously studied as a Fulbright scholar at the National Center of Biotechnology, living in Madrid for a year. She also spent a year living in Jerusalem, Israel.
As an undergraduate at Princeton University, she received a bachelor’s degree in molecular biology and a minor in quantitative and computational biology. During her research, Jillian designed a drug screen to quantitatively describe regimes of Erk activity in a primary murine cell line.



